Evidence map›Paper›PMID 30556733›Full record

ArticleExperimental and clinical psychopharmacology2019

Tobacco and cannabis co-use: Drug substitution, quit interest, and cessation preferences.

Erin A McClure, Rachel L Tomko, Claudia A Salazar, Saima A Akbar, Lindsay M Squeglia, Evan Herrmann, Matthew J Carpenter, Erica N Peters

Abstract read
In one paragraph

Article in Experimental and clinical psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Erin A McClureDepartment of Psychiatry and Behavioral Sciences.ORCID 0000-0001-9744-7818
Rachel L TomkoDepartment of Psychiatry and Behavioral Sciences.ORCID 0000-0002-6961-4399
Claudia A SalazarDepartment of Psychiatry and Behavioral Sciences.
Saima A AkbarDepartment of Psychiatry and Behavioral Sciences.
Lindsay M SquegliaDepartment of Psychiatry and Behavioral Sciences.
Evan HerrmannBattelle Public Health Center for Tobacco Research.
Matthew J CarpenterDepartment of Psychiatry and Behavioral Sciences.
Erica N PetersBattelle Public Health Center for Tobacco Research.

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Southern Consortium Node of the Clinical Trials Network (Varenicline)UG1DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KATHLEEN T. BRADY, Kelly S. Barth · 2015 to 2026
$24.8M
A Randomized Controlled Trial of Varenicline for Adolescent Smoking CessationU01DA031779 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GRAY, KEVIN M · 2012 to 2016
$3.3M
N-Acetylcysteine and Contingency Management for Youth Cannabis Use DisorderR01DA042114 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GRAY, KEVIN M · 2017 to 2021
$3.1M
Neuroscience-informed Treatment Development for Adolescent Alcohol Use DisordersK23AA025399 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SQUEGLIA, LINDSAY · 2016 to 2020
$1.0M
Technological Innovations for the Remote Monitoring of Smoking in AdolescentsK01DA036739 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI MCCLURE, ERIN A · 2014 to 2018
$771k
National Institute on Alcohol Abuse and AlcoholismNational Institute on Drug AbuseNCATS NIH HHS UL1 TR001450NIAAA NIH HHS K23 AA025399NIDA NIH HHS K01 DA036739NIDA NIH HHS R01 DA042114NIDA NIH HHS U01 DA031779NIDA NIH HHS UG1 DA013727
6 · The paper itself

Abstract

The co-use of tobacco and cannabis is a common practice worldwide and carries with it substantial public health burden. Few interventions exist that target both substances and little is known about quit interest, treatment preferences, and drug substitution during past cessation attempts, which is critical to guide the development of treatment strategies. The goal of this study was to provide descriptive information regarding quit interest, treatment preferences, and perceived drug substitution among adult (age 18 +) cannabis-tobacco co-users. Participants (

Indexed as

AdultAgedCigarette SmokingDrug SubstitutionFemaleHumansMaleMarijuana SmokingMiddle AgedMotivationSmoking CessationSurveys and QuestionnairesTobacco ProductsTobacco UseUnited StatesYoung Adult

Identifiers

PMID30556733
PMCPMC6538467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.